We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.62B
AUM Growth
+$77.5M
Cap. Flow
-$61.1M
Cap. Flow %
-3.78%
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.14M
2
AVGO icon
Broadcom
AVGO
+$3.01M
3
TSLA icon
Tesla
TSLA
+$2.23M
4
TWST icon
Twist Bioscience
TWST
+$1.76M
5
NVAX icon
Novavax
NVAX
+$1.74M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$26.2M
2
DHR icon
Danaher
DHR
+$17.1M
3
AMGN icon
Amgen
AMGN
+$12.4M
4
GILD icon
Gilead Sciences
GILD
+$9.52M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 33.28%
2 Healthcare 16.86%
3 Consumer Discretionary 11.45%
4 Communication Services 8.63%
5 Energy 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
226
Ionis Pharmaceuticals
IONS
$9.35B
$1.3M 0.08%
36,409
+20,564
+130% +$772K
MDGL icon
227
Madrigal Pharmaceuticals
MDGL
$12.6B
$1.3M 0.08%
5,366
+4,233
+374% +$1.15M
CRSP icon
228
CRISPR Therapeutics
CRSP
$4.58B
$1.29M 0.08%
28,609
+19,876
+228% +$965K
EXPE icon
229
Expedia Group
EXPE
$31.2B
$1.29M 0.08%
13,309
-700
-5% -$73.4K
PRTA icon
230
Prothena Corp
PRTA
$458M
$1.29M 0.08%
+26,531
New +$1.4M
AWK icon
231
American Water Works
AWK
$26.3B
$1.28M 0.08%
8,767
+46
+0.5% +$6.81K
RARE icon
232
Ultragenyx Pharmaceutical
RARE
$2.65B
$1.28M 0.08%
31,901
+24,081
+308% +$1.03M
IRWD icon
233
Ironwood Pharmaceuticals
IRWD
$611M
$1.28M 0.08%
121,495
+103,109
+561% +$1.16M
PCVX icon
234
Vaxcyte
PCVX
$7.89B
$1.28M 0.08%
+34,086
New +$1.45M
C icon
235
Citigroup
C
$222B
$1.28M 0.08%
27,230
-9,803
-26% -$481K
BCRX icon
236
BioCryst Pharmaceuticals
BCRX
$2.37B
$1.27M 0.08%
+152,754
New +$1.47M
NTRA icon
237
Natera
NTRA
$37.5B
$1.27M 0.08%
22,842
+10,679
+88% +$513K
FOLD
238
DELISTED
Amicus Therapeutics
FOLD
$1.26M 0.08%
113,441
+89,783
+380% +$1.11M
DOW icon
239
Dow Inc
DOW
$21.6B
$1.25M 0.08%
22,857
-2,387
-9% -$134K
DE icon
240
Deere & Co
DE
$170B
$1.25M 0.08%
3,026
+389
+15% +$161K
DASH icon
241
DoorDash
DASH
$75.3B
$1.25M 0.08%
19,626
-1,798
-8% -$103K
NET icon
242
Cloudflare
NET
$93B
$1.25M 0.08%
20,193
-4,397
-18% -$240K
CRWD icon
243
CrowdStrike
CRWD
$187B
$1.24M 0.08%
36,220
-6,700
-16% -$194K
ES icon
244
Eversource Energy
ES
$28.2B
$1.24M 0.08%
15,817
-888
-5% -$70.1K
AKAM icon
245
Akamai
AKAM
$16.8B
$1.24M 0.08%
15,776
+1,832
+13% +$148K
IOVA icon
246
Iovance Biotherapeutics
IOVA
$2.23B
$1.23M 0.08%
+202,037
New +$1.39M
RXDX
247
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$1.23M 0.08%
+11,488
New +$1.32M
HZNP
248
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.23M 0.08%
11,236
-14,041
-56% -$1.55M
EIX icon
249
Edison International
EIX
$30.7B
$1.22M 0.08%
17,348
-968
-5% -$65.4K
TRV icon
250
Travelers Companies
TRV
$80.8B
$1.22M 0.08%
7,111
-334
-4% -$60.7K

Similar funds

Profund Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.

  • Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
  • Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
  • Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
  • Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
  • Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
  • Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.

Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.